Published in J Ophthalmol on July 02, 2014
Topical ophthalmic lipid nanoparticle formulations (SLN, NLC) of indomethacin for delivery to the posterior segment ocular tissues. Eur J Pharm Biopharm (2016) 0.78
Solid lipid nanoparticles for parenteral drug delivery. Adv Drug Deliv Rev (2004) 2.10
Epithelial thickness in the normal cornea: three-dimensional display with Artemis very high-frequency digital ultrasound. J Refract Surg (2008) 2.02
Effects of cyclodextrins on drug delivery through biological membranes. J Pharm Sci (2007) 1.60
Mathematical modeling and simulation of drug release from microspheres: Implications to drug delivery systems. Adv Drug Deliv Rev (2006) 1.59
Solid lipid nanoparticles for enhancing vinpocetine's oral bioavailability. J Control Release (2006) 1.52
Lutein: more than just a filter for blue light. Prog Retin Eye Res (2012) 1.49
Diffusion of high molecular weight compounds through sclera. Invest Ophthalmol Vis Sci (2000) 1.43
Physical and chemical stability of drug nanoparticles. Adv Drug Deliv Rev (2011) 1.34
Drug delivery to the posterior segment of the eye. Drug Discov Today (2010) 1.23
Inhibitory effects of lutein on endotoxin-induced uveitis in Lewis rats. Invest Ophthalmol Vis Sci (2006) 1.15
Oxidative stress in diseases of the human cornea. Free Radic Biol Med (2008) 1.13
Polysaccharide-decorated nanoparticles. Eur J Pharm Biopharm (2004) 1.08
rhEGF/HP-beta-CD complex in poloxamer gel for ophthalmic delivery. Int J Pharm (2002) 1.02
Transscleral drug delivery to the retina and choroid. Prog Retin Eye Res (2002) 0.97
Nanomaterials for ocular drug delivery. Macromol Biosci (2012) 0.96
Surfactant, but not the size of solid lipid nanoparticles (SLN) influences viability and cytokine production of macrophages. Int J Pharm (2001) 0.93
Porcine sclera as a model of human sclera for in vitro transport experiments: histology, SEM, and comparative permeability. Mol Vis (2009) 0.93
Lutein protects RGC-5 cells against hypoxia and oxidative stress. Int J Mol Sci (2010) 0.91
Pharmaceutical applications of cyclodextrins: effects on drug permeation through biological membranes. J Pharm Pharmacol (2011) 0.91
Barrier analysis of periocular drug delivery to the posterior segment. J Control Release (2010) 0.90
Nanostructured lipid carrier (NLC) coated with Chitosan Oligosaccharides and its potential use in ocular drug delivery system. Int J Pharm (2010) 0.89
In vitro permeation studies comparing bovine nasal mucosa, porcine cornea and artificial membrane: androstenedione in microemulsions and their components. Eur J Pharm Biopharm (2004) 0.89
Cytotoxicity of submicron emulsions and solid lipid nanoparticles for dermal application. Int J Pharm (2007) 0.87
Do nutritional supplements have a role in age macular degeneration prevention? J Ophthalmol (2014) 0.87
Solid lipid nanoparticles for ocular drug delivery. Drug Deliv (2010) 0.86
Cyclodextrins as solubilizers: formation of complex aggregates. J Pharm Sci (2010) 0.85
Cyclodextrin-mediated enhancement of riboflavin solubility and corneal permeability. Mol Pharm (2013) 0.84
2-Hydroxypropyl-β-cyclodextrin-modified SLN of paclitaxel for overcoming p-glycoprotein function in multidrug-resistant breast cancer cells. J Pharm Pharmacol (2012) 0.84
Nanostructured lipid carriers as novel ophthalmic delivery system for mangiferin: improving in vivo ocular bioavailability. J Pharm Sci (2012) 0.84
Mucoadhesive effect of thiolated PEG stearate and its modified NLC for ocular drug delivery. J Control Release (2009) 0.83
Enhancement of stability and skin permeation by sucrose stearate and cyclodextrins in progesterone nanoemulsions. Int J Pharm (2010) 0.83
Protective effect of ascorbic Acid against corneal damage by ultraviolet B irradiation: a pilot study. Cornea (2008) 0.82
Dexamethasone eye drops containing γ-cyclodextrin-based nanogels. Int J Pharm (2012) 0.82
Determination of carotenoids in vegetable foods and plasma. Int J Vitam Nutr Res (1997) 0.81
Pharmacokinetic and pharmacodynamic evaluation of the anti-cataract effect of eye drops containing disulfiram and low-substituted methylcellulose using ICR/f rats as a hereditary cataract model. Biol Pharm Bull (2012) 0.79
Development of sucrose stearate-based nanoemulsions and optimisation through γ-cyclodextrin. Eur J Pharm Biopharm (2011) 0.78
Efficacy of Ethanol Extract of Fructus lycii and Its Constituents Lutein/Zeaxanthin in Protecting Retinal Pigment Epithelium Cells against Oxidative Stress: In Vivo and In Vitro Models of Age-Related Macular Degeneration. J Ophthalmol (2013) 0.78
Comparative cytoprotection of cultured corneal endothelial cells by water-soluble antioxidants against free-radical damage. Cornea (1995) 0.77
Drug penetration of the posterior eye tissues after topical instillation: in vivo and in silico simulation. Chem Pharm Bull (Tokyo) (2011) 0.76